Improvement in right ventricular strain with ambrisentan and tadalafil upfront therapy in scleroderma-associated pulmonary arterial hypertension

American Journal of Respiratory and Critical Care Medicine

Volumn 197, Issue 3, 2018, Pages 388-391

  Mercurio, Valentina ^a   Mukherjee, Monica ^a   Tedford, Ryan J ^a   Zamanian, Roham T ^b   Khair, Rubina M ^a,c   Sato, Takahiro ^a,c   Minai, Omar A ^c   Torres, Fernando ^d   Girgis, Reda E ^e   Chin, Kelly ^d   Damico, Rachel ^a   Kolb, Todd M ^a   Mathai, Stephen C ^a   Hassoun, Paul M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMBRISENTAN; TADALAFIL; PHENYLPROPIONIC ACID DERIVATIVE; PYRIDAZINE DERIVATIVE;

CARDIOVASCULAR MAGNETIC RESONANCE; DISEASE ASSOCIATION; HUMAN; HYPERKINESIA; HYPOKINESIA; LETTER; M MODE ECHOCARDIOGRAPHY; MULTICENTER STUDY (TOPIC); OPEN STUDY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SCLERODERMA; SPECKLE TRACKING ECHOCARDIOGRAPHY; TWO DIMENSIONAL ECHOCARDIOGRAPHY; AGED; CINE MAGNETIC RESONANCE IMAGING; CLINICAL TRIAL; COHORT ANALYSIS; COMBINATION DRUG THERAPY; COMPLICATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG EFFECT; FEMALE; FOLLOW UP; HEART CONTRACTION; HEART RIGHT VENTRICLE FUNCTION; LIMITED SCLERODERMA; MALE; MIDDLE AGED; MULTICENTER STUDY; OBSERVER VARIATION; PATHOPHYSIOLOGY; PREVENTION AND CONTROL; PROCEDURES; PROSPECTIVE STUDY; TREATMENT OUTCOME;

AGED; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION, PULMONARY; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; OBSERVER VARIATION; PHENYLPROPIONATES; PROSPECTIVE STUDIES; PYRIDAZINES; SCLERODERMA, LIMITED; TADALAFIL; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 85045270933     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201704-0789le     Document Type: Letter

References (11)

1. Rubenfire M, Huffman MD, Krishnan S, Seibold JR, Schiopu E, McLaughlin VV. Survival in systemic sclerosis with pulmonary arterial hypertension has not improved in the modern era. Chest 2013;144: 1282-1290.
2. Rhee RL, Gabler NB, Sangani S, Praestgaard A, Merkel PA, Kawut SM. Comparison of treatment response in idiopathic and connective tissue disease-associated pulmonary arterial hypertension. Am J Respir Crit Care Med 2015;192:1111-1117.
3. Gali N, Barber JA, Frost AE, Ghofrani HA, Hoeper MM, McLaughlin VV, et al.; AMBITION Investigators. Initial use of ambrisentan plus tadalafil in pulmonary arterial hypertension. N Engl J Med 2015; 373:834-844.
4. Hassoun PM, Zamanian RT, Damico R, Lechtzin N, Khair R, Kolb TM, et al. Ambrisentan and tadalafil up-front combination therapy in scleroderma-associated pulmonary arterial hypertension. Am J Respir Crit Care Med 2015;192:1102-1110.
5. Vonk-Noordegraaf A, Haddad F, Chin KM, Forfia PR, Kawut SM, Lumens J, et al. Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology. J Am Coll Cardiol 2013; 62(25, Suppl)D22-D33.
6. Mercurio V, Mukherjee M, Tedford RJ, Zamanian RT, Khair R, Sato T, et al. Improved right ventricular chamber size and contractility after upfront combination therapy with ambrisentan and tadalfil in scleroderma-associated pulmonary arterial hypertension. Am J Respir Crit Care Med 2017;195:A1044.
7. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2015;28:1-39.e14.
8. Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010;23:685-713, quiz 786-788.
9. Fine NM, Chen L, Bastiansen PM, Frantz RP, Pellikka PA, Oh JK, et al. Reference values for right ventricular strain in patients without cardiopulmonary disease: a prospective evaluation and meta-analysis. Echocardiography 2015;32:787-796.
10. Coghlan JG, Gali N, Barber JA, Frost AE, Ghofrani HA, Hoeper MM, et al.; AMBITION Investigators. Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial. Ann Rheum Dis 2017;76:1219-1227.
11. Mukherjee M, Chung SE, Ton VK, Tedford RJ, Hummers LK, Wigley FM, et al. Unique abnormalities in right ventricular longitudinal strain in systemic sclerosis patients. Circ Cardiovasc Imaging 2016;9:e003792.